. . "Lung Neoplasms diagnosis." . . "Canadian Partnership Against Cancer. Lung Cancer Screening Expert Panel." . . "Medical screening Methodology." . . "Mass Screening methods." . . "Lungs Cancer Diagnosis." . . "Lung Cancer Screening Expert Panel summary of existing and new evidence" . . "Screening portfolio" . . . . . . "Electronic books" . . . . . . . "Statement of the Panel -- Purpose -- Background and Lung Cancer Epidemiology: Importance, Mortality and Incidence; Survival; Histological Distribution and Trends; Stage at Diagnosis; Risk Factors; Smoking Trends: Prevalence Data -- Principles of Screening and Biases: Screening Biases; Acceptability; Validity; Efficacy and Effectiveness; Demonstration of Effectiveness -- Lung Cancer Screening Tests: Chest X-Ray; Low-Dose Computed Tomographic Scanning; Non-Imaging Tests -- Follow-up of Screen-Detected Abnormalities and Management of Disease -- Lung Cancer Screening Trials/Studies: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial; International Early Lung Cancer Action Program; National Lung Screening Trial; Dutch-Belgian Randomized Lung Cancer Screening Trial and Danish Randomized Lung Cancer CT Screening Trial -- Summary of Trials -- Risks and Benefits: Radiation Risks and Lung Cancer Screening; Risks of Downstream Investigation for LDCT-Detected Lung Nodules; Incidental Findings -- Adoption into Public Health Practices: Policy; Education; Resources; Follow-up Investigation and Treatment -- Quality Control in Lung Cancer Screening: LDCT Scans; Reaching High-Risk Populations; Implications for Family Practice -- Knowledge Gaps, Research Needs and Future Considerations -- Appendix 1: NLST Estimation of Canadian Lung Cancer Deaths Preventable by LDCT Screening -- References." .